These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11248854)

  • 1. [In vitro models of intestinal and alveolar epithelium cultures in pharmaceutical research].
    Lehr CM
    ALTEX; 2001; 18(1):59-63. PubMed ID: 11248854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Marker transport across biological barriers in vitro: comparison of cell culture models for the gastrointestinal barrier, the blood-brain barrier and the alveolar epithelium of the lung].
    Gindorf C; Steimer A; Lehr CM; Bock U; Schmitz S; Haltner E
    ALTEX; 2001; 18(3):155-64. PubMed ID: 11565049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of human alveolar epithelial cells in primary culture: morphological characterization and synthesis of caveolin-1 and surfactant protein-C.
    Fuchs S; Hollins AJ; Laue M; Schaefer UF; Roemer K; Gumbleton M; Lehr CM
    Cell Tissue Res; 2003 Jan; 311(1):31-45. PubMed ID: 12483282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of cell culture models for the intestine and the blood-brain barrier and comparison of drug permeation.
    Bock U; Flötotto T; Haltner E
    ALTEX; 2004; 21 Suppl 3():57-64. PubMed ID: 15057409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
    Sakagami M
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent.
    Hausheer FH; Kochat H; Parker AR; Ding D; Yao S; Hamilton SE; Petluru PN; Leverett BD; Bain SH; Saxe JD
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S3-15. PubMed ID: 12819940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.
    Lehr CM
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):119-60. PubMed ID: 7600586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro.
    Reichl S
    J Pharm Pharmacol; 2008 Mar; 60(3):299-307. PubMed ID: 18284809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do we need a "Chair of alternative methods", and where?
    Wendel A
    ALTEX; 2002; 19(2):64-8. PubMed ID: 12098011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human primary bronchial lung cell constructs: the new respiratory models.
    Bérubé K; Prytherch Z; Job C; Hughes T
    Toxicology; 2010 Dec; 278(3):311-8. PubMed ID: 20403407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture.
    Marrero Ponce Y; Cabrera Pérez MA; Romero Zaldivar V; González Díaz H; Torrens F
    J Pharm Pharm Sci; 2004 Jun; 7(2):186-99. PubMed ID: 15367375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
    Prestwich GD
    Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three Rs potential in the development and quality control of pharmaceuticals.
    Hartung T
    ALTEX; 2001; 18 Suppl 1():3-13. PubMed ID: 11854852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of different drug transport routes in permeability screening.
    Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
    J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
    Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases.
    Fasano A
    Mol Genet Metab; 1998 May; 64(1):12-8. PubMed ID: 9682213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of transgenic animals in biomedical research in Germany. Part 2: Ethical evaluation of the use of transgenic animals in biomedical research and perspectives for the changeover in research to research animal-free methods].
    Sauer UG; Kolar R; Rusche B
    ALTEX; 2006; 23(1):3-16. PubMed ID: 16477343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.